Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients

dc.contributor.authorSarafidis, Pantelis A.
dc.contributor.authorRuilope Urioste, Luis Miguel
dc.contributor.authorLoutradis, Charalampos
dc.contributor.authorGorostidi, Manuel
dc.contributor.authorSierra, Alejandro de la
dc.contributor.authorCruz, Juan J. de la
dc.contributor.authorVinyoles, Ernest
dc.contributor.authorDivisón Garrote, Juan Antonio
dc.contributor.authorSegura, Julián
dc.contributor.authorBanegas, José R.
dc.date.accessioned2018-05-10T14:23:18Z
dc.date.available2018-05-10T14:23:18Z
dc.date.issued2018
dc.description.abstractObjective: Increased BP-variability predicts cardiovascular morbidity and mortality in hypertensives. This study aimed to examine short-term BP-variability according to renal function stage. Methods: We included 16 546 patients [10 270 (62.1%) without/6276 (38.9%) with CKD Stage 1–5] from the Spanish Ambulatory-Blood-Pressure Monitoring (ABPM) Registry. Stages of CKD were defined according to K/DIGO criteria, based on estimated glomerular filtration rate calculated with the CKD-EPI equation and albumin-to-creatine ratio. BP-variability was assessed with standard deviation (SD), weighted SD (wSD), coefficient of variation (CV), and average real variability (ARV). Results: Compared with those without CKD, a lower proportion of CKD patients were dippers (51.9 versus 39.6%; P < 0.001). Across CKD stages, a progressive decrease in dipper (from 39.1 to 20.4%; P < 0.001) and increase in riser proportion (from 12.3 to 36.7%; P < 0.001) were noted. Patients with CKD had significantly higher SBP SD, wSD, CV and ARV and lower DBP SD compared with those without CKD (P < 0.001). Within CKD Stages, an increasing trend from Stage 1 towards Stage 5 was observed for SBP SD (from 13.8 ± 3.7 to 15.6 ± 5.4 mmHg), wSD (from 12.0 ± 3.2 to 13.9 ± 5.1 mmHg), CV (from 10.4 ± 2.7 to 11.5 ± 4.1%), ARV (from 9.9 ± 2.3 to 11.4 ± 3.2 mmHg); P < 0.001 for all comparisons. DBP SD (P < 0.001), wSD and ARV (P = 0.002) were slightly decreasing, whereas DBP CV increased from Stage 1 to Stage 4 (P < 0.001). In multivariate analysis, male gender, older age, abdominal obesity, diabetes, number of antihypertensive medications, and clinic SBP were independent factors for higher SBP 24-h ARV in CKD. Conclusion: An increase in short-term SBP-variability was present with advancing CKD stages in a large cohort. This increased SBP-variability may be involved in the sharp elevation of cardiovascular risk with worsening renal function.spa
dc.description.filiationUEMspa
dc.description.impact4.209 JCR (2018) Q1, 13/65 Peripheral Vascular Diseasespa
dc.description.impact1.649 SJR (2018) Q1, 35/188 Physiology, 52/365 Cardiology and Cardiovascular Medicine, 12/141 Internal Medicinespa
dc.description.impactNo data IDR 2018spa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationSarafidis, P. A., Ruilope, L. M., Loutradis, C., Gorostidi, M., Sierra, A., Cruz, J., ... & Banegas, J. R. (2018). Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients. Journal of Hypertension, 36(5), 1076-1085. https://doi.org/10.1097/HJH.0000000000001670spa
dc.identifier.doi10.1097/HJH.0000000000001670
dc.identifier.issn0263-6352
dc.identifier.issn1473-5598
dc.identifier.urihttp://hdl.handle.net/11268/7248
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.uemCardiopatía coronariaspa
dc.subject.uemHipertensiónspa
dc.subject.uemObesidadspa
dc.subject.unescoEnfermedad cardiovascularspa
dc.titleBlood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patientsspa
dc.typejournal articlespa
dspace.entity.typePublication

Files